Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
05/2003
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/28/2003EP1313708A1 Quinoline antibacterial compounds and methods of use thereof
05/28/2003EP1313707A1 Quinoline derivatives as anti-inflammation agents
05/28/2003EP1313706A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/28/2003EP0850222B1 Piperazine derivatives and process for the preparation thereof
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420113A Method for preparing Menglusitena and intermediate preparation thereof
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6570016 Process for preparing a 10,11-methanodibenzosuberane derivative
05/27/2003US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
05/27/2003US6569870 Fluorinated quinolones as antimitotic and antitumor agents
05/27/2003US6569544 Electroluminescent device
05/27/2003CA2412553A1 Bridged perinones/quinophthalones
05/27/2003CA2104297C 4-sulfanimide-quinoline nmda antagonists
05/22/2003WO2003042206A1 Pyridinone and pyrimidinone compounds
05/22/2003WO2003042180A1 Process for producing optically active oxoheptenoic acid ester
05/22/2003WO2003042179A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097000 2-Phenyl-quinoline derivatives, preparation method and therapeutic use thereof
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096138 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes
05/22/2003CA2468497A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311485A1 Processes for preparing cilostazol
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311299A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1071656B1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same
05/21/2003EP0874827B1 Quinoline derivatives as nk3 antagonists
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419544A Process for the preparation of quinolylpropenal
05/21/2003CN1419543A Process for preparing quinolylacrylonitrile and intermediates therefor
05/21/2003CN1419466A Sublimation purifying method and apparatus
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1418879A Process for preparing 8-methoxy-quinolone
05/21/2003CN1418875A Ciprofloxacin mandelate, ofloxacin mandelate and preparation process thereof
05/20/2003US6566520 Support for synthesis and purification of compounds
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566362 Use as topical antibiotics
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/15/2003WO2003040256A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003WO2003040104A1 Dimeric pharmaceutical compounds and their use
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039547A1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039488A2 A method for treating inflammatory bowel disease
05/15/2003WO2003039461A2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030089305 Sublimation and purification method
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466143A1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/14/2003EP1309577A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin
05/14/2003EP1140935B1 1,2-annelated quinoline derivatives
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/13/2003US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
05/13/2003US6562976 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
05/13/2003US6562972 Method for preparing quinoxaline-5- and 6-carboxylic acids (I) which comprises contacting an aqueous alkaline suspension of a 5- or 6-halomethyl quinoxaline (II) with oxygen in the presence of a transition metal catalyst, to form the
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003CA2211681C Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037870A1 Substituted 1h-quinolin-2-one compounds
05/08/2003WO2003037866A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 277